{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:10:46Z","timestamp":1771913446080,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["MH060353"],"award-info":[{"award-number":["MH060353"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["MH080097"],"award-info":[{"award-number":["MH080097"]}]},{"name":"University of Pennsylvania Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jad.2017.11.028","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T14:02:39Z","timestamp":1510149759000},"page":"379-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression"],"prefix":"10.1016","volume":"227","author":[{"given":"Lorenzo","family":"Lorenzo-Luaces","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Amsterdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"DeRubeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.11.028_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000284607","article-title":"Psychopathology, temperament, and past course in primary major depressions","volume":"22","author":"Akiskal","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.jad.2017.11.028_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2015.05.070","article-title":"Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: a randomized, double-blind, parallel-group, prospective study","volume":"185","author":"Amsterdam","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.11.028_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.115.169375","article-title":"Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate","volume":"208","author":"Amsterdam","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1994.tb05705.x","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH)","volume":"37","author":"Baber","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2017.11.028_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2017.11.028_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0028-3908(02)00012-6","article-title":"Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate","volume":"42","author":"Bonavita","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2017.11.028_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.ajp.2013.13020225","article-title":"Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD","volume":"171","author":"Deckersbach","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-0327(85)90068-0","article-title":"Bipolar II","volume":"8","author":"Endicott","year":"1985","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.11.028_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1037\/a0014699","article-title":"Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis","volume":"14","author":"Feingold","year":"2009","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.jad.2017.11.028_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1176\/appi.ajp.157.6.956","article-title":"Anxiety as a correlate of response to the acute treatment of bipolar I disorder","volume":"157","author":"Feske","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib11","doi-asserted-by":"crossref","unstructured":"First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2001. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I\/P W\/PSY SCREEN). Biometrics Research, New York State Psychiatric Institute. Retrieved from: \u3008http:\/\/dx.doi.org\/10.1037\/t05063-000\u3009.","DOI":"10.1037\/t05063-000"},{"key":"10.1016\/j.jad.2017.11.028_bib12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0032985","article-title":"Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression","volume":"81","author":"Forand","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2017.11.028_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.59.10.905","article-title":"Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder","volume":"59","author":"Frank","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib14","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","article-title":"Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder","volume":"283","author":"Gelenberg","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2017.11.028_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v62n07a12","article-title":"Effectiveness and safety of long-term antidepressant treatment in bipolar disorder","volume":"62","author":"Ghaemi","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/appi.ajp.161.1.163","article-title":"Antidepressant treatment in bipolar versus unipolar depression","volume":"161","author":"Ghaemi","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib17","unstructured":"Guy, W., 1976. ECDEU assessment manual for psychopharmacology (Vol. 76): US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"key":"10.1016\/j.jad.2017.11.028_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbtep.2006.11.001","article-title":"A test of the cognitive content specificity hypothesis in depression and anxiety","volume":"39","author":"Lamberton","year":"2008","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/da.20493","article-title":"Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD","volume":"25","author":"Mennin","year":"2008","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.jad.2017.11.028_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2215-0366(15)00209-6","article-title":"Bipolar disorder and anxiety: a comorbidity needing better treatments","volume":"2","author":"Mitchell","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3758\/CABN.3.3.207","article-title":"Functional neuroanatomy of emotions: a meta-analysis","volume":"3","author":"Murphy","year":"2003","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.jad.2017.11.028_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S2215-0366(15)00112-1","article-title":"Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis","volume":"2","author":"Pavlova","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4088\/JCP.09m05019yel","article-title":"Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report","volume":"71","author":"Perlis","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/NMD.0000000000000666","article-title":"Psychometric properties of the reconstructed hamilton depression and anxiety scales","volume":"205","author":"Porter","year":"2017","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2017.11.028_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005053-198708000-00005","article-title":"Taking the measure of anxiety and depression validity of the reconstructed hamilton scales","volume":"175","author":"Riskind","year":"1987","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2017.11.028_bib27","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":"Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"161","author":"Simon","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cpr.2014.11.002","article-title":"Psychological therapy for anxiety in bipolar spectrum disorders: a systematic review","volume":"35","author":"Stratford","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2017.11.028_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2007.03.014","article-title":"Effect of comorbid anxiety on treatment response in bipolar depression","volume":"104","author":"Tohen","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.11.028_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00004714-200012000-00009","article-title":"Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment","volume":"20","author":"Walker","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.11.028_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1037\/0021-843X.114.4.522","article-title":"Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V","volume":"114","author":"Watson","year":"2005","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jad.2017.11.028_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0021-843X.104.1.3","article-title":"Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales","volume":"104","author":"Watson","year":"1995","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jad.2017.11.028_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the hamilton depression rating scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.028_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/a0030133","article-title":"The structure of psychopathology: toward an expanded quantitative empirical model","volume":"122","author":"Wright","year":"2013","journal-title":"J. Abnorm. Psychol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271731073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271731073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:23:30Z","timestamp":1759022610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271731073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"alternative-id":["S016503271731073X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.11.028","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}